Validation of prognostic models among patients with advanced heart failure.

[1]  P. Rizzon,et al.  Prediction of mortality in mild to moderately symptomatic patients with left ventricular dysfunction. The role of the New York Heart Association classification, cardiopulmonary exercise testing, two-dimensional echocardiography and Holter monitoring. , 1994, European heart journal.

[2]  D. DeMets,et al.  Effect of Carvedilol on the Morbidity of Patients With Severe Chronic Heart Failure: Results of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study , 2002, Circulation.

[3]  K. Swedberg,et al.  Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). , 1988, The American journal of cardiology.

[4]  M. Packer,et al.  Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure. , 1986, Circulation.

[5]  A. di Lenarda,et al.  Restrictive left ventricular filling pattern in dilated cardiomyopathy assessed by doppler echocardiography: Clinical, echocardiographic and hemodynamic correlations and prognostic implications , 1993 .

[6]  S G Thompson,et al.  Survival of patients with a new diagnosis of heart failure: a population based study , 2000, Heart.

[7]  K. Weber,et al.  Cardiopulmonary Exercise Testing: Physiologic Principles and Clinical Applications , 1986 .

[8]  M Pine,et al.  Predictions of Hospital Mortality Rates: A Comparison of Data Sources , 1997, Annals of Internal Medicine.

[9]  CIBIS-II Investigators and Committees.  The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial , 1999, The Lancet.

[10]  A. Hoes,et al.  Predicting mortality in patients with heart failure: a pragmatic approach , 2003, Heart.

[11]  H. Dargie,et al.  Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial , 2001, The Lancet.

[12]  A. Gavazzi,et al.  [Effect of carvedilol on outcome after myocardial infarction in patients with left ventricular dysfunction: the CAPRICORN randomized trial]. , 2001, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.

[13]  J. Schwartz,et al.  Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. , 1996, Circulation.

[14]  P. Donnan,et al.  Social deprivation increases cardiac hospitalisations in chronic heart failure independent of disease severity and diuretic non-adherence , 2000, Heart.

[15]  Bittner,et al.  Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. SOLVD Investigators. , 1993, JAMA.

[16]  J. Ware,et al.  A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. , 1996, Medical care.

[17]  C M O'Connor,et al.  Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. , 1997, Journal of the American College of Cardiology.

[18]  R Dietz,et al.  Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group. , 2000, JAMA.

[19]  M. Walsh,et al.  Randomized trial of a daily electronic home monitoring system in patients with advanced heart failure: the Weight Monitoring in Heart Failure (WHARF) trial. , 2003, American heart journal.

[20]  F. Alla,et al.  Differential clinical prognostic classifications in dilated and ischemic advanced heart failure: the EPICAL study. , 2000, American heart journal.

[21]  Peter C Austin,et al.  Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. , 2003, JAMA.

[22]  M. Quiñones,et al.  Echocardiographic predictors of clinical outcome in patients with left ventricular dysfunction enrolled in the SOLVD registry and trials: significance of left ventricular hypertrophy. Studies of Left Ventricular Dysfunction. , 2000, Journal of the American College of Cardiology.

[23]  J. Cohn,et al.  The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. , 1996, The New England journal of medicine.

[24]  W. Kübler,et al.  Risk stratification in middle‐aged patients with congestive heart failure: prospective comparison of the Heart Failure Survival Score (HFSS) and a simplified two‐variable model , 2001, European journal of heart failure.

[25]  C M O'Connor,et al.  Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. , 2001, Archives of internal medicine.

[26]  D. Levy,et al.  The epidemiology of heart failure: the Framingham Study. , 1993, Journal of the American College of Cardiology.

[27]  William J. Rogers,et al.  Prediction of Mortality and Morbidity With a 6-Minute Walk Test in Patients With Left Ventricular Dysfunction , 1993 .

[28]  John Wikstrand,et al.  Effects of Controlled-Release Metoprolol on Total Mortality, Hospitalizations, and Well-being in Patients with Heart Failure: The Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF) , 2000 .

[29]  R. Carney,et al.  A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. , 1995, The New England journal of medicine.

[30]  L Goldman,et al.  Correlates of early hospital readmission or death in patients with congestive heart failure. , 1997, The American journal of cardiology.

[31]  William M. Tierney,et al.  Using electronic medical records to predict mortality in primary care patients with heart disease , 2007, Journal of General Internal Medicine.

[32]  E. Philbin,et al.  Socioeconomic status as an independent risk factor for hospital readmission for heart failure. , 2001, The American journal of cardiology.

[33]  J. Rouleau,et al.  Long-term prognosis of patients presenting to the emergency room with decompensated congestive heart failure. , 1994, The Canadian journal of cardiology.

[34]  X Marchandise,et al.  Right ventricular ejection fraction is an independent predictor of survival in patients with moderate heart failure. , 1998, Journal of the American College of Cardiology.

[35]  P. Armstrong,et al.  A systematic review of randomized trials of disease management programs in heart failure. , 2001, The American journal of medicine.